Braly PS - Search Results

1

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.

Muggia FM, Braly PS, Brady MF, Sutton G, Niemann TH, Lentz SL, Alvarez RD, Kucera PR, Small JM. Muggia FM, et al. Among authors: braly ps. J Clin Oncol. 2000 Jan;18(1):106-15. doi: 10.1200/JCO.2000.18.1.106. J Clin Oncol. 2000. PMID: 10623700 Clinical Trial.

2

Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin.

Stratton JA, Kucera PR, Rettenmaier MA, Dobashi K, Micha JP, Braly PS, Berman ML, DiSaia PJ. Stratton JA, et al. Among authors: braly ps. Gynecol Oncol. 1986 Nov;25(3):302-10. doi: 10.1016/0090-8258(86)90081-8. Gynecol Oncol. 1986. PMID: 3781341

3

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.

Rothenberg ML, Liu PY, Braly PS, Wilczynski SP, Hannigan EV, Wadler S, Stuart G, Jiang C, Markman M, Alberts DS. Rothenberg ML, et al. Among authors: braly ps. J Clin Oncol. 2003 Apr 1;21(7):1313-9. doi: 10.1200/JCO.2003.07.031. J Clin Oncol. 2003. PMID: 12663720 Clinical Trial.

4

The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experience.

Stratton JA, Kucera PR, Micha JP, Rettenmaier MA, Braly PS, Berman ML, DiSaia PJ. Stratton JA, et al. Among authors: braly ps. Gynecol Oncol. 1984 Nov;19(3):336-47. doi: 10.1016/0090-8258(84)90201-4. Gynecol Oncol. 1984. PMID: 6500376

5

A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.

Oza AM, Matulonis UA, Alvarez Secord A, Nemunaitis J, Roman LD, Blagden SP, Banerjee S, McGuire WP, Ghamande S, Birrer MJ, Fleming GF, Markham MJ, Hirte HW, Provencher DM, Basu B, Kristeleit R, Armstrong DK, Schwartz B, Braly P, Hall GD, Nephew KP, Jueliger S, Oganesian A, Naim S, Hao Y, Keer H, Azab M, Matei D. Oza AM, et al. Clin Cancer Res. 2020 Mar 1;26(5):1009-1016. doi: 10.1158/1078-0432.CCR-19-1638. Epub 2019 Dec 12. Clin Cancer Res. 2020. PMID: 31831561 Free PMC article. Clinical Trial.

6

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities.

Gandara DR, Nahhas WA, Adelson MD, Lichtman SM, Podczaski ES, Yanovich S, Homesley HD, Braly P, Ritch PS, Weisberg SR, et al. Gandara DR, et al. Among authors: braly p. J Clin Oncol. 1995 Feb;13(2):490-6. doi: 10.1200/JCO.1995.13.2.490. J Clin Oncol. 1995. PMID: 7844610 Clinical Trial.

7

Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.

Brewer M, Angioli R, Scambia G, Lorusso D, Terranova C, Panici PB, Raspagliesi F, Scollo P, Plotti F, Ferrandina G, Salutari V, Ricci C, Braly P, Holloway R, Method M, Madiyalakan M, Bayever E, Nicodemus C. Brewer M, et al. Gynecol Oncol. 2020 Mar;156(3):523-529. doi: 10.1016/j.ygyno.2019.12.024. Epub 2020 Jan 6. Gynecol Oncol. 2020. PMID: 31916979 Clinical Trial.

8

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.

Herzog TJ, Monk BJ, Rose PG, Braly P, Hines JF, Bell MC, Wenham RM, Secord AA, Roman LD, Einstein MH, Drake RD, Childs BH. Herzog TJ, et al. Gynecol Oncol. 2014 Mar;132(3):517-25. doi: 10.1016/j.ygyno.2014.01.035. Epub 2014 Jan 27. Gynecol Oncol. 2014. PMID: 24476788 Free PMC article. Clinical Trial.

9

Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.

Morgan RJ Jr, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH. Morgan RJ Jr, et al. Gynecol Oncol. 1999 Dec;75(3):419-26. doi: 10.1006/gyno.1999.5613. Gynecol Oncol. 1999. PMID: 10600300 Clinical Trial.

10

Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial.

Braly PS, Berek JS, Blessing JA, Homesley HD, Averette H. Braly PS, et al. Gynecol Oncol. 1995 Feb;56(2):164-8. doi: 10.1006/gyno.1995.1025. Gynecol Oncol. 1995. PMID: 7896179 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters